Suit Alleges Novartis Orchestrated a Kickback Scheme with Bioscrip, Inc., by Referring New Patients and Giving Rebates to BioScrip in Return for Bioscrip Increasing Refills of Exjade Prescriptions Through Biased Recommendations to Patients, Which Emphasized the Benefits of Refills While Understating Exjade’s Serious, Potentially Life-Threatening Side Effects BioScrip Agrees to Pay $15 Million […]
The post Drug Kickback Scheme Sees Lawsuits Against Novartis and Lawsuit Settled Against Bioscrip appeared first on LawFuel.
Related Stories
- Southern California Man Pleads Guilty to Attempting to Assist Al-Qai’da by Providing Weapons Training to Fighters in Pakistan
- Skadden Arps Advises The Jones Group on Sycamore Partners’ Acquisition
- Attorney General Bondi and OFR Commissioner Breakspear Sue Consumer Finance Companies for Illegal Interest and Annual Percentage Rates